发明授权
US07662782B2 Melanocortin 1 receptor selective compounds 失效
黑皮质素1受体选择性化合物

Melanocortin 1 receptor selective compounds
摘要:
The invention relates to methods of treatment comprising administering a compound of the general formula (1): to a patient or a healthy individual.
公开/授权文献
信息查询
0/0